Immunity-mediated diseases and human immunogenetics (accomplishments and prospects)
Type 1 diabetes mellitus (T1DM) was used from the viewpoint of human immunogenetics as an example of the most widely studied immunity-mediated disease. This was done in order to develop, approve and implement a new clinical approach to determine immunity-mediated susceptibility or resistance to auto...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/705508fe96a2421c890aeda42561fbbe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:705508fe96a2421c890aeda42561fbbe |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:705508fe96a2421c890aeda42561fbbe2021-11-14T09:00:20ZImmunity-mediated diseases and human immunogenetics (accomplishments and prospects)2072-03512072-037810.14341/DM7775https://doaj.org/article/705508fe96a2421c890aeda42561fbbe2016-01-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7775https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Type 1 diabetes mellitus (T1DM) was used from the viewpoint of human immunogenetics as an example of the most widely studied immunity-mediated disease. This was done in order to develop, approve and implement a new clinical approach to determine immunity-mediated susceptibility or resistance to autoimmune diseases. The approach is based on analysis of entire HLA-DRB1 genotypes (not separate HLA-DRB1 haplotypes) of the study participants. Therefore, more effective and personalised classification of T1DM risk groups was achieved by exclusion from significant contingents.Ivan Ivanovich DedovRakhim Musaevich KhaitovLeonid Petrovich AlexeevEndocrinology Research Centrearticletype 1 diabetes mellitusimmunogeneticsimmunity-mediated diseasesNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 19, Iss 1, Pp 8-15 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
type 1 diabetes mellitus immunogenetics immunity-mediated diseases Nutritional diseases. Deficiency diseases RC620-627 |
spellingShingle |
type 1 diabetes mellitus immunogenetics immunity-mediated diseases Nutritional diseases. Deficiency diseases RC620-627 Ivan Ivanovich Dedov Rakhim Musaevich Khaitov Leonid Petrovich Alexeev Immunity-mediated diseases and human immunogenetics (accomplishments and prospects) |
description |
Type 1 diabetes mellitus (T1DM) was used from the viewpoint of human immunogenetics as an example of the most widely studied immunity-mediated disease. This was done in order to develop, approve and implement a new clinical approach to determine immunity-mediated susceptibility or resistance to autoimmune diseases. The approach is based on analysis of entire HLA-DRB1 genotypes (not separate HLA-DRB1 haplotypes) of the study participants. Therefore, more effective and personalised classification of T1DM risk groups was achieved by exclusion from significant contingents. |
format |
article |
author |
Ivan Ivanovich Dedov Rakhim Musaevich Khaitov Leonid Petrovich Alexeev |
author_facet |
Ivan Ivanovich Dedov Rakhim Musaevich Khaitov Leonid Petrovich Alexeev |
author_sort |
Ivan Ivanovich Dedov |
title |
Immunity-mediated diseases and human immunogenetics (accomplishments and prospects) |
title_short |
Immunity-mediated diseases and human immunogenetics (accomplishments and prospects) |
title_full |
Immunity-mediated diseases and human immunogenetics (accomplishments and prospects) |
title_fullStr |
Immunity-mediated diseases and human immunogenetics (accomplishments and prospects) |
title_full_unstemmed |
Immunity-mediated diseases and human immunogenetics (accomplishments and prospects) |
title_sort |
immunity-mediated diseases and human immunogenetics (accomplishments and prospects) |
publisher |
Endocrinology Research Centre |
publishDate |
2016 |
url |
https://doaj.org/article/705508fe96a2421c890aeda42561fbbe |
work_keys_str_mv |
AT ivanivanovichdedov immunitymediateddiseasesandhumanimmunogeneticsaccomplishmentsandprospects AT rakhimmusaevichkhaitov immunitymediateddiseasesandhumanimmunogeneticsaccomplishmentsandprospects AT leonidpetrovichalexeev immunitymediateddiseasesandhumanimmunogeneticsaccomplishmentsandprospects |
_version_ |
1718429536858669056 |